RLAY - CIK 0001812364
Relay Therapeutics, Inc. (RLAY) reported revenue of $15.36M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $15.36M | +53.4% |
| FY 2024 | $10.01M | -60.8% |
| FY 2023 | $25.55M | +1749.8% |
| FY 2022 | $1.38M | -54.4% |
| FY 2021 | $3.03M | -96.3% |
| FY 2020 | $82.65M | - |
Relay Therapeutics, Inc. (RLAY) reported revenue of $15.36M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Relay Therapeutics, Inc.'s revenue declined from $82.65M to $15.36M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.